Work

Supplementary Figure 1 from A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma

Year: 2023

Type: supplementary-materials

Abstract: Diagram to represent the treatment course and responses among patients treated within the study. *Patient had progressive disease of cutaneous KS but continued with treatment due to improvement in symptomatic pulmonary KS.

DOI: 10.1158/1078-0432.22471608

Authors: Ramya Ramaswami, Thomas S. Uldrick, Mark N. Polizzotto, Kathleen M. Wyvill, Priscila Goncalves, Anaida Widell, Kathryn Lurain, Seth M. Steinberg, William Douglas Figg, Giovanna Tosato, Denise Whitby, Robert Yarchoan

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362406608

Cites:

Cited by:

Related to: 10